Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02158585 · ClinicalTrials.gov registry record · Phase 2
Study of Lamotrigine to Treat Ménière's Disease
A Phase 2 study, sponsored by Dent Neuroscience Research Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT02158585 is a Phase 2 study that has completed, run by Dent Neuroscience Research Center. The registered enrollment target is 15 participants.
The verdict
NCT02158585, a Phase 2 study, has completed, sponsored by Dent Neuroscience Research Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
This double-blinded study evaluates the frequency of vertigo attacks and the quality of life of patients diagnosed with Ménière's disease after being randomly assigned to take a placebo or lamotrigine.
Interventions
- DRUG Placebo
- DRUG Lamotrigine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2014-06 |
| Est. Completion | 2017-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02158585
The ClinicalTrials.gov registry entry for NCT02158585 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dent Neuroscience Research Center, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02158585 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02158585 about?
NCT02158585 is a clinical study titled "Study of Lamotrigine to Treat Ménière's Disease". This double-blinded study evaluates the frequency of vertigo attacks and the quality of life of patients diagnosed with Ménière's disease after being randomly assigned to take a placebo or lamotrigine.
What is the current status of trial NCT02158585?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2014-06. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02158585?
The interventions under investigation include: Placebo (DRUG), Lamotrigine (DRUG).
Who is sponsoring clinical trial NCT02158585?
This trial is sponsored by Dent Neuroscience Research Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.